APA (7th ed.) Citation

S, S., C, S., AW, K., JL, C., J, J., & JS, M. (2025). Impact of endocrine therapy regimens for early-stage ER+/HER2-breast cancer on contralateral breast cancer risk. NPJ breast cancer, 11(1), 30. https://doi.org/10.1038/s41523-025-00746-7

Chicago Style (17th ed.) Citation

S, Sarkar, Schechter C, Kurian AW, Caswell-Jin JL, Jayasekera J, and Mandelblatt JS. "Impact of Endocrine Therapy Regimens for Early-stage ER+/HER2-breast Cancer on Contralateral Breast Cancer Risk." NPJ Breast Cancer 11, no. 1 (2025): 30. https://doi.org/10.1038/s41523-025-00746-7.

MLA (9th ed.) Citation

S, Sarkar, et al. "Impact of Endocrine Therapy Regimens for Early-stage ER+/HER2-breast Cancer on Contralateral Breast Cancer Risk." NPJ Breast Cancer, vol. 11, no. 1, 2025, p. 30, https://doi.org/10.1038/s41523-025-00746-7.